Skip to main content
. 2019 Jun 7;10:1266. doi: 10.3389/fmicb.2019.01266

Table 1.

Antifungal susceptibility testing and drug interaction evaluation between ITC and VER against A. fumigatus.

Strain MIC (μg/ml)
Alone
Combined
ITC-VER interaction
ITC VER ITC VER FICI Interpretationa
Afc03 0.25 > 9600 0.0625 40 < 0.254 SYN
Afc06 0.25 > 9600 0.0625 40 < 0.254 SYN
Afc07 0.25 > 9600 0.0625 80 < 0.258 SYN
Afc18 0.5 > 9600 0.125 80 < 0.258 SYN
Af1161 0.25 > 9600 0.0625 80 < 0.258 SYN
Af293 0.25 > 9600 0.25 80 < 1.008 NI
Shjt40 8 > 9600 1 960 < 0.225 SYN
Shjt42b 16 > 9600 16 960 < 1.1 NI
Afc3-339 16 > 9600 4 480 < 0.3 SYN
Afc6-75 2 > 9600 0.25 480 < 0.175 SYN
Afc7-233 16 > 9600 16 960 < 1.1 NI
Af1161-73 16 > 9600 4 480 < 0.3 SYN
Af1161-132 8 > 9600 2 960 < 0.35 SYN
Af1161-78 16 > 9600 2 960 < 0.225 SYN
Af1161-185 16 > 9600 4 480 < 0.3 SYN
Af1161-331 16 > 9600 2 960 < 0.225 SYN
Af1161-353 16 > 9600 8 960 < 0.6 NI

aAbbreviations: FICI, fractional inhibitory concentration index; ITC, itraconazole; NI, no interaction; SYN, synergism; VER, verapamil. Clinical-derived isolates susceptible to itraconazole. Clinical-derived isolates resistant to itraconazole (8).